All News about Roivant Sciences Ltd
The Analyst Landscape: 4 Takes On Roivant Sciences
February 14, 2024
Via Benzinga
Assessing Roivant Sciences: Insights From 5 Financial Analysts
January 02, 2024
Via Benzinga
Analyst Ratings for Roivant Sciences
December 12, 2023
Via Benzinga
8 Analysts Have This to Say About Roivant Sciences
November 14, 2023
Via Benzinga
Roivant Sciences Earnings Preview
February 12, 2024
Via Benzinga
Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
December 20, 2023
From Roivant Sciences
Via GlobeNewswire
Roivant Sciences Earnings Preview
November 10, 2023
Via Benzinga
From Roivant Sciences
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|